When Norman was diagnosed with an aggressive form of acute myeloid leukemia (AML), doctors told him the odds were against him. When it came time for a bone marrow transplant, no donors could be found. Then a woman in Germany, who signed up for the registry two days prior, emerged as a match.
In the treatment of cancer, one size does not fit all. At Jazz, our researchers are committed to discovering new possibilities for delivering innovative treatments as effectively and safely as possible.
Jazz strives to create a workplace culture that supports a diverse, multicultural workforce and provides an inclusive environment where all employees are empowered to contribute and succeed.
Low Intensity Therapy for first-line, unfit AML (Phase 1b)
CPX-3513
Low Intensity Dosing for higher risk MDS
IMGN6321
CD123+ Hematological malignancies5
PHASE 2
Defibrotide
Prevention of aGvHD
Defibrotide4
Treatment of TA-TMA
Defibrotide4
Prevention of CAR-T associated neurotoxicity
CPX-351 + venetoclax3
de novo or R/R AML
CPX-3516
HR-MDS
CPX-3516
R/R AML (COG)
CPX-3514,6
Newly diagnosed older adults with HR-AML
CPX-351 + venetoclax4,6
HR-AML
JZP-458 (Recombinant Crisantaspase)4
ALL (Phase 2/3)
PHASE 3
JZP-258
Cataplexy & EDS in narcolepsy
JZP-258
Idiopathic hypersomnia
Defibrotide
Prevention of VOD
CPX-3516
AML or HR-MDS (AML19)
CPX-3516
AML or HR-MDS (AML18)
CPX-3516
Newly diagnosed adults with standard- and HR-AML
CPX-3514,6
Newly diagnosed pediatric patients
REGULATORY
Solriamfetol EU
EDS in OSA and Narcolepsy
Sleep
Hematology / Oncology
1Opt-in opportunity
2Partnered collaboration
3Jazz & MD Anderson Cancer Center collaboration study
4Planned
5Including AML and BPDCN
6Cooperative group study
Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully.
By unlocking biopharmaceutical discoveries to develop novel medicines, we are giving thousands of people around the world the opportunity to redefine what’s possible.
Thank you for contacting Jazz Pharmaceuticals Corporate Development & Partnering
Sending data...
Contact Corporate Development / Partnering
Personal Information(All fields are required)
Please provide details on this opportunity
This website uses cookies to help us provide you with a more responsive and
personalized service. By using this website without changing your cookie
settings, you agree to our use of cookies. For more information on how
we use cookies and how to delete or block the use of cookies, please
see our Privacy Statement. By clicking on Accept you consent to our use of cookies.
Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue.
